Breaking News Bar

Business News and Information

Cancer drug company Epizyme prices IPO, begins trading

Epizyme Inc. has priced its initial public offering at $15 a share –— the top of the expected range — and will start trading on the Nasdaq Friday under the ticker symbol, "EPZM...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear